Understanding how certain brain receptors affect learning and memory in autism.

Mechanism of Gp1 mGluR-dependent translation and plasticity

NIH-funded research University of Illinois at Urbana-Champaign · NIH-10954715

This study is looking at how certain brain receptors help with learning and memory, especially in people with autism, and it aims to understand how a specific protein might affect these receptors to find new ways to improve thinking skills.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Illinois at Urbana-Champaign NIH-funded
Lab location1 site (Champaign, United States)
Project IDNIH-10954715 on NIH RePORTER

What this research studies

This research investigates the role of Group 1 metabotropic glutamate receptors (Gp1 mGluRs) in the brain, focusing on their involvement in synaptic plasticity, which is essential for learning and memory. The study aims to explore how a specific protein, Mdm2, influences the activity of these receptors and their ability to support neuronal adaptation. By using animal models, particularly those related to autism spectrum disorders, the research seeks to uncover the underlying mechanisms that could lead to new therapeutic strategies. Patients may benefit from insights gained about how to improve cognitive functions affected by these disorders.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with autism spectrum disorders or related conditions.

Not a fit: Patients without autism spectrum disorders or those with unrelated neurological conditions may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that enhance learning and memory in individuals with autism spectrum disorders.

How similar studies have performed: Previous research has shown promising results in understanding the role of Gp1 mGluRs in neurological disorders, indicating that this approach has potential for success.

Where this research is happening

Champaign, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions autism spectral disorderautism spectrum disorderautism-fragile X (AFRAX) syndromeAutistic Disorderautistic spectrum disorder
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.